Adial Pharma to Implement 1 for 25 Reverse Split for Nasdaq Compliance; Shares Drop

Adial Pharmaceuticals (ADIA) will implement a 1 for 25 reverse stock split effective February 10, 2026, to regain compliance with the NASDAQ's minimum share price requirement. The move follows a stock price that fell below $1.00 per share. The split is projected to increase the stock price by a factor of 25, potentially bringing it back above the $1.00 floor. ADIA shares closed at $0.42 on February 4, 2026, down 21.4% in pre-market trading.